This site uses cookies to store information on your computer. I'm fine with this Cookie information

Commercial Contract Agreements

Before any commercial study can proceed within NHS GG&C a written agreement between the Board and the commercial company should be signed by both parties. Contracts should only be negotiated by Research Co-ordinators and are signed by an R&D director. The agreement should define the following: 

  • Scope of work 
  • Acceptable payment arrangements
  • Important issues such as the right to publish results
  • Protection of confidential information
  • Indemnification of third parties.   
To help facilitate timely completion of the appropriate contractual documentation, the Association of British Pharmaceutical Industry (ABPI) and the Department of Health have developed, and published, a model Clinical Trials Agreement (mCTA) as a standard contractual framework for commercial trials involving NHS patients. To incorporate slight differences in Scottish Law and policy, a revised mCTA for use in Scotland has been developed. All legal agreements between the Board and commercial companies should be governed by the laws of Scotland. Legal advice on any aspect of the mCTA can be obtained from the CLO. Examples of CTA's can be found here: